Dr Reddy’s Laboratories on Thursday said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs used to treat heart diseases and cancer in India.

The Hyderabad-based firm said it has entered into a strategic collaboration with Amgen to market and distribute three Amgen medicines in India in oncology and cardiology, Dr Reddy’s Laboratories said in a statement.

Under the terms of the collaboration, Dr Reddy’s shall undertake a full range of regulatory and commercial services to seek approval and launch the three drugs — Kyprolis, Blincyto and Repatha — in India.

Help employers find you! Check out all the jobs and post your resume.

Source: BioSpace Featured News